Disparities in Linking Children to Hepatitis C Care Uncovered

Recent research highlights significant disparities in the process of linking children diagnosed with hepatitis C virus (HCV) to appropriate care. The study, published online April 18 in Pediatrics, analyzed the care cascade among children born from 2000 to 2018 who received an HCV diagnosis before age 18. Findings revealed that only 32% of these children were connected to HCV care, and merely 12% received direct-acting antivirals (DAAs), a modern treatment option.
The analysis showed notable racial and ethnic disparities: Hispanic/Latinx children and white children had twice and three times the odds, respectively, of being linked to care compared to Black children. This indicates ongoing inequities in access and treatment within the pediatric HCV care pathway.
Researchers Megan Rose Curtis, M.D., from Washington University in St. Louis, and colleagues emphasized that these gaps disproportionately affect marginalized populations. They suggest that improving linkage programs—such as patient navigation, training primary care providers to treat adolescents with HCV, and offering treatment immediately upon diagnosis in nonclinical settings—could help bridge these disparities.
Addressing these gaps is essential for reducing the burden of hepatitis C among children and ensuring equitable healthcare delivery. The study underscores the need for targeted interventions to improve the care cascade for vulnerable groups.
Source: [https://medicalxpress.com/news/2025-04-disparities-linkage-children-hepatitis.html]
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
How Biological Sex Influences Immune Responses and Disease Risks
Understanding how biological sex influences immune responses provides crucial insights into disease susceptibility and personalized medicine. Discover the latest research from La Jolla Institute on sex differences in immunity and disease risks.
Waist-to-Height Ratio Surpasses BMI in Identifying Liver Disease Risks
A new study reveals that waist-to-height ratio outperforms BMI in predicting fatty liver and cirrhosis risk, offering an accessible tool for early detection globally.
Innovative Approach to In Vivo Blood Stem Cell Gene Therapy Discovered
Researchers have uncovered a critical early postnatal window to effectively deliver gene therapy directly into blood stem cells, offering new hope for treating genetic blood disorders in infants without invasive procedures.



